TG Therapeutics
TGTX
TGTX
213 hedge funds and large institutions have $1.42B invested in TG Therapeutics in 2023 Q1 according to their latest regulatory filings, with 54 funds opening new positions, 61 increasing their positions, 61 reducing their positions, and 36 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
213
Holders Change
+16
Holders Change %
+8.12%
% of All Funds
3.41%
Holding in Top 10
4
Holding in Top 10 Change
+4
Holding in Top 10 Change %
%
% of All Funds
0.06%
New
54
Increased
61
Reduced
61
Closed
36
Calls
$41.9M
Puts
$21.1M
Net Calls
+$20.8M
Net Calls Change
-$6.1M
Top Buyers
1 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$157M |
2 |
JFG
Jefferies Financial Group
New York
|
+$76.7M |
3 |
GTC
Ghost Tree Capital
New York
|
+$16.5M |
4 |
SSA
Schonfeld Strategic Advisors
New York
|
+$15.1M |
5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$12.8M |
Top Sellers
1 |
Millennium Management
New York
|
-$53.6M |
2 |
MC
Maverick Capital
Dallas,
Texas
|
-$51.1M |
3 |
State Street
Boston,
Massachusetts
|
-$41.7M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$31.9M |
5 |
WP
Woodline Partners
San Francisco,
California
|
-$30.3M |